PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 22202

Semaglutide: Diabetes

Original

answeredUnited Kingdom· UK Parliament· EN

Introduced

16 April 2024

Last action

22 April 2024 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

22 April 2024

Summary

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from t

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 16 April 2024

    Written question

    To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from t

    Source: Commons

  2. 22 April 2024

    Answer

    The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, th...

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.